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INTRODUCTION
Epidemiological studies have analyzed the impact of dietary
components on the incidence of breast cancer (1-7). While
there has been no clear consensus on the specific link between
breast cancer development and diet, one study reported that
soya products rich in phytoestrogens may protect against
breast cancer in premenopausal women (1). Foods containing
soybean and ginseng contain large quantities of the iso-
flavones genistein and daidzein, which are phytoestrogens
with weak estrogen agonist activity that may interfere with
the breast cancer promoting effects of physiologic estrogen
(3). Increased soy protein consumption is significantly cor-
related with a reduction in the risk of sex steroid implicated
cancers such as breast cancer and prostate cancer (1, 4). While
a meta-analysis supported a reduced risk of breast cancer
development with intake of vegetables and to a lesser extent
fruit (6), a pooled analysis of cohort studies could verify no
significant reduction in breast cancer risk with either fruit
or vegetable consumption in the adult years (7).
The molecular basis of the effects of ginseng on cell prolif-
eration has not been identified. Previous studies have shown
that American ginseng induces the expression of pS2, an
estrogen regulated gene (8). AG has also been shown to exert
inhibitory growth effects on the hormone dependent MCF-
7 breast cancer cell line (8, 9).
This present investigation focuses on determining a pos-
sible mechanism of action that may account for the breast
cancer cell growth inhibitory properties of AG. The shift
from quiescence (G0) to an actively growing state is a pre-
requisite for entry into the cell cycle in most cells, and it is
crucial step for cancer cells (10). Cell cycle progression is
modulated by certain types of regulators known as cyclin
kinase inhibitors. The first of these proteins to be identified
and cloned was p21 (11-13). The p21 protein, a universal
cell cycle inhibitor, binds cyclin-CDK complexes and pro-
liferating cell nuclear antigen, thereby serving as a potent
growth inhibitor and effector of cell-cycle checkpoint (14).
Induction of p21 expression has been linked to growth
inhibition by p53 (11), and also has been found to signal
growth arrest, independent of p53 in cells undergoing dif-
ferentiation (15-17).
The purpose of this investigation was to determine if Amer-
ican ginseng induces the cell cycle inhibitor p21 in hormone
sensitive MCF-7 and insensitive MDA-MB-231 breast can-
cer cell lines.
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American Ginseng Transcriptionally Activates p21 mRNA in Breast
Cancer Cell Lines 
American ginseng (AG) has been demonstrated to inhibit breast cancer cell
growth in vitro. p21 protein, a universal cell cycle inhibitor, binds cyclin-CDK
complexes, an important mechanism in cell cycle regulation. The purpose of this
investigation was to determine if AG induces p21 gene expression in hormone
sensitive (MCF-7) and insensitive (MDA-MB-231) breast cancer cell lines. Cells
grown in steroid stripped medium (SSM) were treated with AG, 17- -estradiol
(E2), genistein or cycloheximide (CHX). Northern blot analyses were performed
using human p21Cip1 and 36B4 cDNA probes. Cell lines were transiently trans-
fected with select mouse p21 CAT reporter constructs, including those lacking a
p53 binding site. Cell cycle analyses was performed by FACScan. The results
revealed that AG induced p21 mRNA expression in MCF-7 and MDA-MB-231
cells (p=0.0004; p≤0.0001, respectively). Neither E2 nor genistein alter p21
mRNA expression. CHX, a protein synthesis inhibitor, did not block p21 mRNA
expression induced by AG, indicating that p21 is induced as an immediate early
gene. AG activated p21 reporter constructs in transfected cells, independent of
p53 binding sites. The cell cycle proliferative phase was significantly decreased
by AG and increased by E2 (p≤0.0001). AG may inhibit breast cancer cell
growth by transcriptional activation of the p21 gene, independent of p53.
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Cells and cell culture
MCF-7 (estrogen sensitive) and MDA-MB-231 (estrogen
insensitive) breast cancer cell lines and the HT-29 colon
cancer cell line were purchased from American Type Culture
Collection (ATCC, Rockville, MD). The cells were grown
in 75 cm2 flasks for northern blot analyses, 100 mm culture
plates for transient transfection and 25 cm2 flasks for cell
cycle analyses, respectively, at 37℃ and 5% CO2 in Eagle’ s
Minimum Essential Medium (EMEM, Biowhittaker, MD)
and supplemented with 10% fetal bovine serum, 584 mg/L
L-glutamine and 5×10-2 mg/mL gentamicin until the cells
were grown to 70% confluence. The medium was changed
every 2 to 3 days and the cells were split by trypsinization
when they reached confluence.
The breast cancer cell lines were stripped of endogenous
steroid hormone by successive passages in phenol red free
Dulbeco’ s Modified Eagle’ s Medium (DMEM, Biowhittak-
er, MD) containing 5% charcoal and dextran treated fetal
bovine serum, 584 mg/mL L-glutamine, 0.2 IU/mL insulin
and 5×10-2 mg/mL gentamicin (18).
After 7 days of steroid withdrawal, the breast cancer cell
lines were treated with select concentrations (50 to 2,000
g/mL) of a standardized American ginseng (AG) extract
(Panax quinquefolium grown in Canada), (gift, CNT2000,
Chi Na Ta Corp, Langley, British Columbia), 17- -estradi-
ol (E2), (10-9 M, Sigma Chemical Company, St. Louis, MO),
genistein (Gn), (10-6 M, Sigma) or cycloheximide (CHX),
(10  g/mL, Sigma) for 1 to 48 hr and the medium and test
compounds were replenished at 24 hr (19).
HT-29 colon cancer cells were treated with 5 mM of sodi-
um butyrate for four hours as the positive control group for
p21 mRNA expression (20).
Northern blot analyses
Total RNA was extracted by the single step method using
Ultraspec RNA Isolation system (BIOTECX Laboratories,
Houston, TX). Twenty micrograms of total RNA was elec-
trophoresed onto a 1% agarose gel containing formaldehyde
and transferred to a nylon membrane. The transferred RNA
was crosslinked to a nylon membrane using UV stratalinker
(Stratagene, La Jolla, CA). p21, a 1.009 kb Xho1/Ecor1 frag-
ment derived from the human Cip1 cDNA (ATCC) and
36B4 cDNA were labeled with 32P-dCTP by the random
primer method (21) to a specific activity of 5×108 cpm/ g
DNA using Oligolabelling kit (Pharmacia Biotech, Piscat-
away, NJ). The membranes were prehybridized for 16 hr,
and then hybridized in 50% formamide/6× standard saline
citrate (SSC)/0.5% sodium dodecyl sulfate (SDS)/5% Den-
hart’ s solution/100  g/mL salmon sperm DNA/0.001 M
EDTA at 42℃ for 16 hr. The cells were washed twice in 2
×SSC/0.2% SDS, twice in 1×SSC/0.2% SDS at room
temperature and twice in 0.5×SSC/0.2% SDS at 65℃. The
washed filters were exposed to Kodak BioMax MR film at -
70℃. The level of p21 mRNA expression was determined
by using laser densitometry and Image Quant software
(Molecular Dynamics 400-B 2D, Sunnyvaly, CA) and nor-
malized for RNA content using the 36B4 cDNA control.
Transient transfection and Chloramphenicol Acetyl-
transferase (CAT) Assays
The cells were grown at 50-60% confluence in 100 mm
tissue culture plates and were transiently transfected with
10-20 g  of  p21 CAT reporter plasmids containing selected
portions of the p21 promoter constructs (gift, Tayler Jacks,
Howard Hughes Medical Institute, Center for Cancer Re-
search, MIT, Cambridge, MA.) from 0 to 4.7 kb upstream
of the transcriptional start site or empty vector, pJFCAT by
using the CaPO4/DNA coprecipitation technique (Strata-
gene) (22). After 24 hr of transfection, the transfectants were
treated with or without AG 2,000  g/mL for 24 hr, then
harvested by direct scraping followed by washing with phos-
phate buffered saline (PBS). Total protein was isolated in
150-200  L of 0.25 M Tris-HCl. The concentration of the
isolated protein was measured by CobasBio system (ROCHE
Diagnostic, Nutley, NJ). Reaction products were applied
onto a thin layer chromatography plate (23) and results of
thin layer chromatography were recorded by standard instant
photography using 55 positive negative film (Polaroid, Cam-
bridge, MA) and were analyzed by densitometry scanning.
Flow cytometry
When the confluence of the cells reached 70% in 25 cm2
flasks in standard or steroid stripped medium, the cells were
treated with 10-9 M E2 or 60 to 2,000  g/mL AG. Culture
media and test compounds were replenished at 24 hr. Forty-
eight hours after either E2 or AG treatment, cells were har-
vested by trypsinization, collected in 15 mL polyethylene
tubes, and washed twice with phosphate buffered saline
(PBS), and fixed in 70% ethanol. For DNA analyses, cells
were centrifuged, and the pellet was stained with propidi-
um iodide (PI, 50  g/mL) dissolved in 50  g/mL DNAse
free RNAse and 0.1% Tritan X-100 (24-25). The cell pel-
lets were dispersed by repeated pipetting and were placed at
room temperature in the dark for 30 min. The DNA con-
tent fluorescence due to PI was measured by flow cytometry
(FACScan, Becton Dickinson, San Jose, CA) on a minimum
of 10,000 cells in the band above 620 nm. Data were recorded
on Cell Quest software (Becton Dickinson) after an electronic
gating of nuclear aggregates by the doublet discriminating
module. The percentage of each cell cycle component was
calculated from the histogram with ModFit (Becton Dick-
inson).
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Fisher’ s PLSD of the ANOVA test and mean±s.d. were
used for statistical analyses and a p-value less than 0.05 was
considered statistically significant.
RESULTS
American ginseng induces p21 mRNA
All experiments for northern blot analyses were performed
in steroid stripped medium (SSM). Positive and negative
controls, including cells grown in standard medium (SM)
were utilized for all experiments. The doses of American
ginseng (AG) tested ranged from 50 to 2,000  g/mL and
the time of treatment ranged from 1 to 48 hr.
AG induced a dose-dependent increase in p21 mRNA
expression in MCF-7 and MDA-MB-231 breast cancer cell
lines. The greatest increase in p21 mRNA expression was
identified with the AG 2,000  g/mL treatment dose (p=
0.0004; p≤0.0001, respectively). Neither E2 nor Gn induced
p21 mRNA expression in the MCF-7 or MDA-MB-231
breast cancer cell lines.
p21 mRNA induction by AG 2,000  g/mL was identified
as early as 1 hr after initiation of treatment in both MCF-7
and MDA-MB-231 cell lines and continued to be detected
at an increased level at 48 hr of treatment. At 4 hr of treat-
ment, AG induced a peak p21 mRNA expression by approx-
imately 4-fold in the MCF-7 cells and 3-fold in the MDA-
MB-231 cells (p≤0.0001, both cell lines) in this time course
experiment in comparison to the untreated SSM control
group.
This increase in p21 mRNA expression induced by the
treatment of breast cancer cells by AG was equivalent to the
increase in p21 mRNA induced in the HT-29 colon cancer
cell line positive control group treated with sodium butyrate.
At 48 hr of treatment, there was no detection of p21 mRNA
induced by either E2 or Gn in the MCF-7 or MDA-MB-231
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Fig. 1. Cycloheximide (CHX), the protein synthesis inhibitor, does
not block p21 mRNA expression by American ginseng.
Both MCF-7 (A) and MDA-MB-231 (B) breast cancer cell lines
were treated with AG 2,000  g/mL in the presence or absence of
10  g/mL CHX for 4 hr and 24 hr. p21 mRNA expression induced
by AG was not blocked by concurrent treatment with CHX. There
was no induction of p21 mRNA by E2 alone or in combination with
CHX. There was a 3.8-fold increase in p21 expression in MCF-7
cells treated with AG alone for 4 hr and a 4.2-fold increase in p21
expression when cells were treated with AG and CHX. At 24 hr of
treatment, there was a 2.0-fold increase in p21 mRNA expression
induced when MCF-7 cells were treated with AG alone and a 14.8-
fold increase when treated with AG and CHX compared to the
untreated control group. A 2-fold increase in p21 expression is
noted for HT-29 cells treated with both sodium butyrate and CHX
in comparison to sodium butyrate alone. In (A), the lanes corre-
spond to the following treatments: a=SSM controls; b=E2 (10-9  M)
4 hr; c=E2 (10-9 M) 24 hr; d=AG 4 hr; e=AG 24 hr; f=E2 and CHX 4
hr; g=E2 and CHX 24 hr; h=AG and CHX 4 hr; i=AG and CHX 24
hr; j=HT-29 cells untreated control; k=HT-29 cells treated 4 hr with
sodium butyrate; l=HT-29 cells treated 24 hr with sodium butyrate;
m=HT-29 cells and sodium butyrate and CHX 4 hr; n=HT-29 cells
and sodium butyrate and CHX 24 hr.
A 3.3, 1.2 and 1.5 fold increase in p21 mRNA expression was
detected for MDA-MB-231 cells treated with AG 2,000  g/mL for
4, 24 and 48 hr, respectively, in comparison to untreated controls.
There was a 4.7, 5.8, and 4.7 fold increase in p21 expression when
CHX was added to AG for the same time periods, respectively.
In (B), the lanes correspond to the following treatments: a=SSM
controls; b=AG 4 hr; c=AG and CHX 4 hr; d=AG 24 hr; e=AG
and CXH 24 hr; f=AG 48 hr; g=AG and CHX 48 hr; h=CHX alone.
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Fig. 2. American ginseng induces p21 promoter activity.
MCF-7 and MDA-MB-231 breast cancer cells were transiently
transfected with 10 to 20  g of murine p21 CAT reporter plas-
mid containing selected portions of p21 promoter constructs
(from 0 to 4.7 kb upstream of the transcriptional start site). Trans-
fectants were treated with AG 2,000  g/mL for 24 hr. This his-
togram depicts the percent CAT induction of AG treated cells
compared with the untreated negative control of p21 CAT activi-
ty in MCF-7 and MDA-MB-231 cell line, arbitrarily taken as
100%. *p≤0.05.
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Bbreast cancer cell lines.
Fig. 1A and B illustrates the results of the concomitant
treatment of the MCF-7 and MDA-MB-231 breast cancer
cell lines with AG and the protein synthesis inhibitor, CHX,
respectively. This experiment demonstrated that p21 mRNA
expression induced by AG treatment is not blocked by CHX.
Both AG and CHX increased p21 levels greater than either
AG or CHX alone, indicating that p21 is induced as an im-
mediate early gene and is superinducible by cycloheximide
in wild type cells.
American ginseng induces p21 gene expression in
breast cancer cells, independent of p53 binding sites
The CAT reporter plasmids under the control of various
portions of the mouse p21 gene 5′ flanking region (from 0
to 4.7 kb upstream of the transcriptional initiation site) were
transiently transfected into MCF-7 and MDA-MB-231 cells.
The transfectants were treated with AG 2,000  g/mL. AG
induced p21 promoter activity in both MCF-7 and MDA-
MB-231 cells, from 1.4 to 4.7 kb, even in those plasmids
lacking the two p53 binding sites, located at -2.85 and -1.95
upstream from the transcriptional start site. AG activated
the mouse p21 CAT plasmids in both cell lines, in compari-
son to that of the pJFCAT empty vector. The experiments
were repeated four times to confirm the results. The results
are shown in the histogram Fig. 2.
American ginseng induces growth arrest in breast
cancer cells
Cell cycle analysis was performed in MCF-7 and MDA-
MB-231 cell lines in steroid stripped medium (SSM) and
standard medium (SM). It has been previously demonstrat-
ed that culture medium contains various growth factors and
steroid hormones that may influence the outcome of hor-
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Fig. 3. Effect of American Ginseng and Estradiol on the Prolifera-
tive Phase (% S-Phase) of the Cell Cycle in Breast Cancer Cell
Lines.
MCF-7 and MDA-MB-231 breast cancer cell lines were grown in
either standard medium (SM) or steroid stripped medium (SSM)
and treated for 48 hr with either AG (2,000  g/mL), E2 (10-9 M) or
SM/SSM as a control group. DNA content was determined by
FACScan flow cytometry (n=4). The graph represents the mean
±s.d. For both cell lines grown in SM, AG significantly decreased
the % S-phase (p≤0.001 for both) while AG had no significant
effect on cells grown in SSM in comparison to the control groups.
E2 significantly increased the %-S-phase in MCF-7 cells grown in
SM (p=0.022) and SSM (p≤0.001). E2 had no significant effect
on MDA-MB-231 breast cancer cells grown in either SM or SSM.
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Fig. 4. Effect of American Ginseng and Estradiol on the Quies-
cent Phase (G0/G1) of the Cell Cycle in Breast Cancer Cell
Lines.
MCF-7 and MDA-MB-231 breast cancer cell lines were grown in
standard medium (SM) and steroid stripped medium (SSM) and
treated for 48 hr with either AG (2,000  g/mL), E2 (10
-9 M) or
SM/SSM as a control group. DNA content was determined by
FACScan flow cytometry (n=4). The graph represents the mean
±standard deviation. For MCF-7 and MDA-MB-231 breast can-
cer cell lines grown in SM, AG significantly increased the G0/G1
phase (p≤0.0001 for both cell lines) in comparison to the
respective control groups. AG also increased the G0/G1 phase
in MCF-7 cells grown in SM (p≤0.01) but had no significant
effect on MDA-MB-231 cells grown in SSM. E2 had no significant
effect on the G0/G1 phase of MCF-7 cells grown in SM or in
MDA-MB-231 cells grown in SM or SSM. E2 did significantly
decrease the G0/G1 phase (p≤0.0001) in MCF-7 cells grown in
SSM in comparison to the control group.
AG E2 Control AG E2 Control AG E2 Control AG E2
Treatment
SM SSM SM SSM
MCF-7 MDA-MB-231monally related experiments (26), hence the effect on the
proliferative (% S-phase) and resting phases (G0/G1) of the
cell cycle was evaluated and compared in both mediums.
Both cells lines were treated with either E2 (10-9 M) or AG
(2,000  g/mL) and a negative control was used for all exper-
iments.
In the MCF-7 cells grown in SM, E2 significantly increased
the % S-phase (p=0.022) and AG significantly decreased
the % S-phase (p≤0.001) compared to the untreated con-
trol groups, as demonstrated in Fig. 3. E2 had no effect on
the G0/G1 phase while AG significantly increased this phase
(p≤0.0001). For MCF-7 cells grown in SSM, E2 significant-
ly increased the % S-phase (p≤0.001) while AG exhibited
a non-significant decrease of  the proliferative phase in this
medium (p=0.10). AG but not E2 increased the G0/G1 phase
(p≤0.01) in SSM cells.
The effect of AG on the % S-phase in MDA-MB-231 cells
grown in SM was similar to that of the MCF-7 cells grown in
SM. AG decreased (p≤0.001) the %-S-phase and increased
the resting phase (p≤0.0001) while E2 (p=NS) had no effect
on either cell cycle phase in this estrogen insensitive cell line.
Neither AG nor E2 had any effect on the % S-phase or G0/G1
phase of MDA-MB-231 cells grown in SSM. The differences
in apoptotic cell counts were minimal between controls and
AG treated breast cancer cells (data not shown). Of note is
the observation that the % S-phase for the control groups
are significantly higher when the cell lines are grown in SM
in comparison to SSM. Fig. 3 and 4 are histogram depictions
of the results of the studies of the % S-phase and the G0/G1
cell cycle phases in MCF-7 and MDA-MB-231 cell lines.
DISCUSSION
The results from this study suggest that one possible mech-
anism of action of inhibition of breast cancer cell growth by
AG may be through a molecular pathway involving the in-
duction of the p21 gene. Induction of p21 by sodium butyrate
in the HT-29 colon cancer cell line served as a model for
this investigation. Butyrate induction of p21 may represent
a molecular link between a high fiber diet and the preven-
tion of colon cancer (20).
One epidemiologic study reported that ginseng may con-
tribute to a reduced risk of cancer development (27), but
there is a paucity of data regarding the molecular mechanism
involving the effects of ginseng on cell proliferation. In this
present investigation, northern blot analyses were performed
to examine the effects of American ginseng on the p21 expres-
sion. These studies established that AG induced p21 mRNA
expression in a time and dose dependent manner in both
hormone sensitive (MCF-7) and insensitive (MDA-MB-231)
breast cancer cell lines. Induction of p21 mRNA expression
was identified as early as 1 hr and peaked at 4 hr after AG
treatment in MCF-7 and MDA-MB-231 cells. The protein
synthesis inhibitor, cycloheximide (CHX) did not block
American ginseng induced p21 expression, indicating that
p21 is an immediate early gene.
This rapid p21 induction is similar to that seen with many
early genes such as Egr-1 (28), c-fos (29), or c-jun (30) that
are induced by mitogenic or other stimuli in the absence of
de novo protein synthesis and thus constitute the first step in
such a cascade. Macleod et al. showed that expression of the
p21 mRNA following serum stimulation is superinducible
by cycloheximide in wild type primary mouse embryonic
fibroblasts (22), similar to the results of these present studies.
Estrogenic steroids perform several major roles in mam-
malian physiology which include control of the development
of the reproductive tract and secondary sex organs. They are
also intimately linked with the development and progres-
sion of a number of human cancers, particularly breast can-
cer, by stimulating progression through G1 phase of the cell
cycle (31). Planas-Silva et al. (32) have shown that cyclin D1
has an important role in steroid-dependent cell proliferation
and that estrogen, by stimulating the activities of G1 cyclin-
dependent kinases, can control the proliferation of breast
cancer cells.
17- -estradiol (E2) was shown to exhibit no effect on p21
mRNA expression in either estrogen sensitive or insensitive
cell lines. E2 increased the % S-phase fraction in MCF-7 cells
but not in MDA-MB-231 cells. These cell cycle studies sup-
port previous studies that indicate that the MCF-7 breast
cancer cell line is not only dependent on estrogen but that
estradiol also has mitogenic effects in this estrogen depen-
dent breast cancer cell line (19). This mitogenic property
appears to be independent of p21 activation.
Several in vivo studies have revealed that estrogen and estro-
gen agonists, such as genistein and daidzein, can act as chemo-
preventive agents to inhibit the development of carcinogen
induced mammary tumors (33-35). Hsieh et al. reported a
biphasic proliferative effect of genistein on MCF-7 cells (36).
This study suggested that low dose genistein (as low as 10-8
M) enhanced the proliferation of MCF-7 cells in vitro, with
a concentration of 10-7 M achieving proliferative effects sim-
ilar to those of 10-9 M estradiol. At concentrations above 2
×10-5 M, however, genistein significantly inhibited MCF-7
cell growth. Since genistein had no effect on p21 expression,
the mechanism of action for cell growth regulation must in-
volve a different molecular event.
It has been shown that induction of p21 following expo-
sure to ionizing radiation or other DNA damaging agents
requires p53 function (37). p53 mediates p21 gene induc-
tion by transactivation through cis-elements located 1.95
and 2.85 kb upstream from the transcriptional initiation
site in the mouse and 2.4 kb upstream in human p21 gene
(11, 22). p53 appears to be independent of p21 expression
during normal mammalian development and cellular differ-
entiation. This data from this present investigation suggests
that AG may possibly achieve its growth inhibition in
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dependent kinase inhibitor, p21, through one or more cis-
element, in a p53 independent fashion.
Since AG induced p21 mRNA expression in a time and
dose dependent manner, flow cytometry studies were per-
formed to determine whether AG would induce growth
arrest in breast cancer cells. This data demonstrate that the
% S-phase fraction of the cell cycle is significantly decreased
by AG in the cells grown in standard medium and to a less-
er degree in steroid stripped medium.
In the northern blot analyses, induction of p21 mRNA
expression by AG begins at a concentration of 50  g/mL in
MCF-7 cells and 500  g/mL in MDA-MB-231 cells. The
peak increase is found at 2,000  g/mL in both MCF-7 and
MDA-MB-231 cells. This is the same dose of this standard-
ized AG extract that has been previously shown to induce
mRNA expression of the estrogen regulated gene pS2 to
equal levels as E2 10-9 M induced pS2 expression (38). In pre-
vious experiments, it had been shown that higher doses of
E2 did not further increase the levels of pS2 mRNA expres-
sion in MCF-7 cells, hence this was the dose used in these
current experiments. This increasing dose response of AG
on p21 mRNA expression is inversely related to the decrease
of S-phase fraction of the cell cycle in standard medium, with
the higher doses of AG resulting in a larger decrease in %
S-phase. For both cell lines, the basal % S-phase fraction was
higher in standard medium than steroid stripped medium.
This is most likely secondary to the lack of growth factors
and steroid hormones in SSM. Passage of cells with phenol
red free medium containing 5% dextran charcoal treated fetal
bovine serum followed by washing with phosphate buffered
saline (PBS) removes not only endogenous steroids but also
various growth factors (26).
Some investigators have shown that p21 binds tightly to
the G1 and S-phase kinases, cyclin E/Cdk2, cyclin D/Cdk 4,
and cyclin A/Cdk2 and inhibits their activity, whereas p21
is a relatively poor inhibitor of the G2/M phase kinase, Cyclin
B/Cdc2 (39). G0/G1 phase was analyzed to investigate cyclin
dependent kinase (CDK) inhibitor of cell cycle progression
as a potential mechanism by which American ginseng neg-
atively regulate cell proliferation. As shown in Fig. 4, AG
induces G0/G1 arrest in both MCF-7 and MDA-MB-231 cells
grown in standard medium, suggesting that the induction
of the CDK inhibitor may be at least partly responsible for
growth arrest induced by AG. Conversely, estradiol signifi-
cantly decreases G0/G1 phase and increases % S-phase of the
cell cycle in MCF-7 cells grown in standard medium, indi-
cating a G1/S transition and a mitogenic effect of E2 on hor-
mone dependent breast cancer cells.
The role of p21 in apoptosis is still not clear. Some inves-
tigators have shown that induction of apoptosis is associated
with upregulation of endogenous p21 (40). However, others
have reported that the p21 gene is not essential for apoptosis
(41) or protects the cells from apoptosis (42, 43). As deter-
mined by FACScan, this study found minimal differences in
apoptotic cell counts between control and American ginseng
treated cells. This result is consistent with the report of Hague
et al., which showed minimal apoptosis in butyrate treated
adherent colon cancer cells, but extensive apoptosis in those
that were floating (44). Since adherent cells and not floating
cells were harvested and subjected to FACScan in order to
identify apoptosis, additional studies will be needed to deter-
mine if American ginseng induces apoptosis.
In conclusion, this investigation demonstrates that Amer-
ican ginseng exhibits breast cancer cell growth inhibitory
properties by a mechanism that may involve transcriptional
upregulation of cyclin dependent kinase inhibitor, p21,
independent of p53.
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